SEHK:823
SEHK:823Retail REITs

A Look At Link REIT (SEHK:823) Valuation After Extended Interim Leadership And CEO Search Update

Leadership changes and why they matter for Link Real Estate Investment Trust Link Real Estate Investment Trust (SEHK:823) is back in focus after Link Asset Management confirmed an extended interim leadership setup, following the former Group CEO’s departure at the end of 2025. Mr. John Russell Saunders, previously Group Chief Investment Officer, has been appointed Executive Director, working alongside Executive Director and Group Chief Financial Officer Mr. Ng Kok Siong under this temporary...
SEHK:6618
SEHK:6618Consumer Retailing

Why JD Health (SEHK:6618) Is Up 13.3% After Strong Quarterly Results And Analyst Endorsement

CICC recently maintained its Buy rating on JD Health International, Inc. and reiterated confidence in the company following a quarter of strong year-over-year revenue and profit growth. This combination of upbeat analyst commentary and improved financial performance has reinforced investor attention on JD Health’s position in China’s online healthcare market. Now, we’ll explore how this stronger quarterly performance may influence JD Health’s existing investment narrative built around...
SEHK:9890
SEHK:9890Entertainment

Tanwan (SEHK:9890) Valuation After HK$468 Million Zero Coupon Convertible Bond Issue

Convertible bond issue puts Tanwan in focus Tanwan (SEHK:9890) has drawn investor attention after completing a HK$468 million zero-coupon convertible bond issue due 2027, a financing move that introduces potential dilution while also adding funding flexibility. See our latest analysis for Tanwan. Tanwan's recent financing comes after a sharp shift in market sentiment, with a 30 day share price return of 29.66% and a 90 day share price return of 50.91%. This has contributed to a very large 1...
SEHK:1193
SEHK:1193Gas Utilities

Assessing China Resources Gas Group (SEHK:1193) Valuation After New Energy Supply Framework Agreement

China Resources Gas Group (SEHK:1193) has entered into a new framework agreement for energy supply transactions, covering metering, internal control measures, and oversight of connected transactions, with the aim of broadening integrated energy services and expanding its customer base. See our latest analysis for China Resources Gas Group. At a share price of HK$21.78, China Resources Gas Group has seen a 90 day share price return of 6.87%, but the 1 year total shareholder return of 17.14%...
SEHK:883
SEHK:883Oil and Gas

CNOOC (SEHK:883) Valuation Check As Buzios6 Production Starts In Brazil

CNOOC (SEHK:883) has reported first oil from the Buzios6 Project in Brazil’s pre salt Buzios field, a large deep water development that lifts the oilfield’s installed capacity to 1.15 million barrels per day. See our latest analysis for CNOOC. Despite the Buzios6 milestone and recent board changes in late December, CNOOC’s HK$20.94 share price sits after a mixed patch, with a 1 day share price return of 1.26% but a 7 day share price return decline of 4.21%, while the 90 day share price return...
SEHK:1208
SEHK:1208Metals and Mining

A Look At MMG (SEHK:1208) Valuation After The Major Khoemacau Copper Mine Expansion Approval

MMG (SEHK:1208) has moved ahead with a major expansion of its Khoemacau Copper Mine in Botswana, committing about US$900 million to increase output capacity and target lower operating costs. See our latest analysis for MMG. That expansion decision comes after a strong run in the stock, with a 30 day share price return of 11.71% and a 90 day share price return of 31.69%, alongside a very large 1 year total shareholder return that points to momentum still building rather than fading. If MMG’s...
SEHK:6855
SEHK:6855Biotechs

A Look At Ascentage Pharma Group International's Valuation After FDA IND Clearance For APG-3288

Ascentage Pharma Group International (SEHK:6855) has drawn fresh attention after announcing that its BTK-targeted protein degrader APG-3288 received U.S. FDA IND clearance, allowing a global Phase I trial in relapsed or refractory B-cell malignancies. See our latest analysis for Ascentage Pharma Group International. The FDA IND clearance for APG-3288 comes as Ascentage Pharma’s share price sits at HK$54.95, with a 1-day share price return of 1.20% and a 7-day share price return of 7.96%,...
SEHK:3692
SEHK:3692Pharmaceuticals

Hansoh Pharmaceutical Group SEHK 3692 Valuation Check After Ameile First Line Lung Cancer Approval

Hansoh Pharmaceutical Group (SEHK:3692) has just received Chinese NMPA approval to expand lung cancer drug Ameile’s use as a first line option in combination therapy for specific EGFR mutated NSCLC patients. See our latest analysis for Hansoh Pharmaceutical Group. The Ameile update comes after a reshuffle of Hansoh Pharmaceutical Group’s board and committees in late December 2025. The latest 1-day share price return of 2.11% at HK$41.6 sits within a year-to-date share price return of 14.16%...
SEHK:1177
SEHK:1177Pharmaceuticals

Assessing Sino Biopharmaceutical (SEHK:1177) Valuation After Fresh IPF And Psoriasis Trial Milestones

Sino Biopharmaceutical (SEHK:1177) has just reported two key clinical milestones, including first patient enrollment in a Phase III trial for IPF drug candidate TDI01 and positive Phase II data for psoriasis treatment TQH3906. See our latest analysis for Sino Biopharmaceutical. The latest clinical updates arrive after a mixed year for Sino Biopharmaceutical’s shares. The stock has a 7.39% year-to-date share price return at HK$6.83, a 12.44% decline over 90 days, and a very large 1-year total...
SEHK:2419
SEHK:2419Food

A Look At Dekon Food And Agriculture Group (SEHK:2419) Valuation After Its Latest Hog Sales And Pricing Update

Why Dekon Food and Agriculture Group’s Latest Sales Update Matters Dekon Food and Agriculture Group (SEHK:2419) has drawn attention after reporting unaudited December 2025 sales, including 1,109.68 thousand heads of pigs sold and RMB1,663.89 million in revenue, alongside a month on month increase in average hog prices. See our latest analysis for Dekon Food and Agriculture Group. Investors appear to be weighing Dekon Food and Agriculture Group’s strong December sales update against recent...